Loading…

Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder

•Higher expression of Kir4.1 in the parietal cortex from depressed patients.•Higher expression of GABAB receptor in the parietal cortex from depressed patients.•Positive correlation between Kir4.1 and GABAB receptor in control group.•No correlation between Kir4.1 and GABAB receptor in depressed pati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of affective disorders 2019-02, Vol.245, p.265-269
Main Authors: Xiong, Zhongwei, Zhang, Kai, Ren, Qian, Chang, Lijia, Chen, Jincao, Hashimoto, Kenji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Higher expression of Kir4.1 in the parietal cortex from depressed patients.•Higher expression of GABAB receptor in the parietal cortex from depressed patients.•Positive correlation between Kir4.1 and GABAB receptor in control group.•No correlation between Kir4.1 and GABAB receptor in depressed patients.•Abnormalities in the interaction of Kir4.1 and GABAB receptor in depression. The inwardly rectifying K+ channel subtype Kir4.1 has been well studied in the astrocyte within brain; however, the precise role of this protein in psychiatric disorders is unknown. Kir4.1 is also known to interact with GABAB receptors which may be implicated in psychiatric disorders. Here we studied whether expression of Kir4.1 and GABAB receptors was altered in the postmortem brain samples (parietal cortex and cerebellum) from patients with major psychiatric disorders. Protein expression of Kir4.1 and GABAB receptors in the parietal cortex and cerebellum from control, major depressive disorder (MDD), schizophrenia (SZ), and bipolar disorder (BD) groups was measured. Levels of Kir4.1 in the parietal cortex from MDD group, but not SZ and BD groups, were significantly higher than the control group. Furthermore, levels of GABAB receptor subunit 1 in the parietal cortex from MDD group and SZ group, but not BD group, were also significantly higher than the control group. Interestingly, there was a positive correlation between Kir4.1 protein and GABAB receptor subunit 1 in the parietal cortex from control group, but not MDD group. The small number in each group may limit our interpretation. Only two brain regions were analyzed. Abnormalities in the interaction of Kir4.1 and GABAB receptor in the parietal cortex might play a role in the pathophysiology of MDD.
ISSN:0165-0327
1573-2517
DOI:10.1016/j.jad.2018.11.016